Navigation Links
Drugs From Vegetables May Target Melanoma Tumors
Date:3/5/2009

Extracts of broccoli, cabbage block protein in disease spread, study says

THURSDAY, March 5 (HealthDay News) -- A drug based on compounds extracted from cruciferous vegetables such as broccoli and cabbage could offer a potent and safe treatment against melanoma, Penn State College of Medicine researchers say.

In mice, a combination of these vegetable compounds (called isothiocyanates) and selenium slowed production and blocked the signaling network of a protein called Akt3 -- which plays a role in melanoma development, -- and reduced tumor growth by 60 percent.

"There are currently no drugs to target the proteins that trigger melanoma. We have developed drugs from naturally occurring compounds that can inhibit the growth of tumors in mice by 50 to 60 percent with a very low dose," Gavin Robertson, an associate professor of pharmacology, pathology and dermatology, said in a Penn State news release.

The potency of isothiocyanates is so low that a useful drug would require impractically large amounts of the compounds. Instead, the researchers altered the vegetable-based compounds by replacing their sulfur bonds with selenium, resulting in a more powerful drug that can be delivered intravenously at low doses. The new drug is called isoselenocyanate.

"Selenium deficiency is common in cancer patients, including those diagnosed with metastatic melanoma. Besides, selenium is known to destabilize Akt proteins in prostate cancer cells," Robertson said.

When the researchers tested the combination drug on different human melanoma cell lines, they found it was from 30 percent to 70 percent effective. Possible human trials of the new drug are still years away.

"We have harnessed something found in nature to target melanoma. And since we only need tiny amounts to kill the cancer cells, it means even less toxic side effects for the patient," said Robertson, who has a provisional patent on the discover
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drugs From Vegetables May Target Melanoma Tumors
(Date:5/23/2013)... Wisconsin (PRWEB) May 23, 2013 Great defined ... is what almost everyone strives to achieve in the gym ... of crunches will not make this goal become a reality. ... habits that are often time overlooked. Scott Tischler of Tischler ... be done to achieve the goal of great abs. , ...
(Date:5/23/2013)... PhD Box has introduced a service that ... process by offering assistance for Thesis Proposals. The proposal writing ... that the company provides for research consultation in various fields. ... writing service is that this is the stage where most ... find it difficult to draft a proposal as it is ...
(Date:5/23/2013)... May 23, 2013 Indosoft Inc., ... for Asterisk telephony, announces major enhancements ... Monitoring and Decision Making System that allows mission ... offer call survival. The new enhancements strengthen automatic ... thereby enhancing reliability. , Large call centers using ...
(Date:5/23/2013)... Georgia (PRWEB) May 23, 2013 Long-Term ... disturbing downtrend in the rate at which applicants for Long ... to buy coverage. , The decision to buy ... decision, but even consumers willing and able to purchase protection ... buy a policy at any price. A variety of ...
(Date:5/23/2013)... Get ready to sweat. , Automatic ... in conjunction with the Nutrié California Kick Off ... participants will get the chance to work out with ... The Dr. Oz Show, and The Dr. Phil Weight ... the undefeated UFC heavy-weight contender Daniel Cormier at Chukchansi ...
Breaking Medicine News(10 mins):Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Indosoft Upgrades its Overseer Watchdog System for Q-Suite to Enhance High Availability with Call Survival for Mission Critical ACD Applications 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout 2Health News:Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout 3
... ... titanium ring studios shows that single women shop for engagement rings before meeting the partner they ... ... design studios, TiRings.com, has revealed evidence that shows a tendency among single women to shop for ...
... ... is the leading supplier of software & technology to Home Medical ... Health Care Agencies. Only Fastrack offers a solution for each ... virtually every clinical, operational and financial aspect of a provider’s business, ...
... The ... and other metal products. In addition to revealing the personality and culture of The Monterey ... pins, and an informal forum for discussions related to such products. , ... (PRWEB) May 8, 2010 -- This year has been a ...
... carbonated soft drinks is not associated with the risk of ... 7 in the Journal of the National Cancer Institute. ... and tea may lower the risk of cancer, but others ... contains anti-oxidants that in theory help prevent cancer but also ...
... ... Beauty, Fighting the Aging Process and Maintaining a Youthful, “Close-Up-Ready” Appearance , ... Los Angeles, CA (PRWEB) May ... have begun to open up about using non-surgical aesthetic procedures to maintain their youthful, ...
... ... religion’s first book this weekend. Published May 9, 1950, “Dianetics: The Modern Science of ... , ... 2010 -- Churches of Scientology around the world celebrate the original release of ...
Cached Medicine News:Health News:Statistics Reveal Women Choose Engagement Rings Before Men 2Health News:Fastrack Acquires Prometheus Group Industry Leading HME Billing Service 2Health News:Monterey Lapel Pin Company Continues Its Website Evolution 2Health News:Monterey Lapel Pin Company Continues Its Website Evolution 3Health News:Coffee and soft drinks have little or no association with colon cancer risk 2Health News:Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures 2Health News:Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures 3Health News:Scientology Churches Celebrate Dianetics 60th Anniversary 2
(Date:5/23/2013)... DIEGO and PARIS , ... VOLC ), a leading developer and manufacturer of precision ... treatment of coronary and peripheral vascular disease, today announced ... V asodilator I ndependent S tenosis ... breaking clinical trial session at EuroPCR 2013. These prospective ...
(Date:5/23/2013)... -- Nederland keurt als eerste nieuwe vaste-dosis ... BPH Astellas Pharma EUROPE ... gebaseerd in Tokyo  ( ... Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) een handelsvergunning ... handelsvergunning verleend voor VESOMNI is voor "de behandeling van ...
(Date:5/23/2013)... , Switzerland and ... 2013 Cenix BioScience, a ... specialized in RNAi-, miRNA- and high content-driven pharmacology, ... group of companies with a focus on the ... needs, including oncology and companion diagnostics, today announced ...
Breaking Medicine Technology:Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4
... PARSIPPANY, N.J. , June 28 Preliminary ... with diabetes and hypertension demonstrated that the investigational triple ... (40/10/25 mg) resulted in a statistically significant greater Least ... at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm ...
... , June 28 Codexis, Inc. (Nasdaq: CDXS ... company as Senior Vice President, Commercial Operations, a new position.  Mr. ... operations worldwide.  He will report to Joseph Sarret , M.D., ... , , , ...
Cached Medicine Technology:New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 2New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 3New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 4New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 5New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 6New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 7Codexis Names Peter Strumph SVP, Commercial Operations 2
... 1-step, hand-held, point-of-care device for the qualitative detection ... The TOX/See device can detect up to ... 3 to 8 minutes and requires only a ... individually packaged to maximize convenience and ease of ...
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
Medicine Products: